Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors
Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.
Read about the current state of the biopharma industry in the face of pending patent cliff.
Meet PCI's newest staff members and read their bios.
John Swartley and Bhavana Mohanraj discuss how working remotely will impact research and innovation hubs.
Learn about Dr. Bruce Levine's predictions for the future uses of Car-T therapy.
Penn ICorps Graduate and President’s Innovation Prize Winner Strella Biotech Raises $8 Million in Series A Funding Round
Read about how this Philadelphia-based agricultural biotech startup received funding from Mark Cuban, Google Ventures, and others.
Gnubiotics and Penn to Explore Car-T Therapy in Combination with Glycopeptides to Target Solid Tumors
This collaboration will take place through company-sponsored pre-clinical research studies in the laboratory of Avery Posey, PhD, an assistant professor at the Perelman School of Medicine.
Regenxbio, a gene therapy company founded through collaboration with PCI, opened a new facility at its Maryland campus.
Five years after Penn and Novartis made history with the FDA approval of Kymriah, a recent study shows the long-term impact of the medication on patient remission rates.
The collaboration between Penn and PaxeraHealth will concentrate on developing imaging algorithms to detect liver cancer in addition to covid detection via lung ultrasounds.